A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer
Keyword(s):
2021 ◽
pp. 1-13
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2021 ◽
Vol 13
(02)
◽
Keyword(s):
Keyword(s):
2009 ◽
Vol 75
(3)
◽
pp. S491